Japan Pharmaceutical Sterility Testing Market Size & Outlook
Japan pharmaceutical sterility testing market, 2018-2030 (US$M)
Related Markets
Japan pharmaceutical sterility testing market highlights
- The Japan pharmaceutical sterility testing market generated a revenue of USD 70.7 million in 2023 and is expected to reach USD 151.1 million by 2030.
- The Japan market is expected to grow at a CAGR of 11.5% from 2024 to 2030.
- In terms of segment, outsourcing was the largest revenue generating type in 2023.
- Outsourcing is the most lucrative type segment registering the fastest growth during the forecast period.
Pharmaceutical sterility testing market data book summary
| Market revenue in 2023 | USD 70.7 million |
| Market revenue in 2030 | USD 151.1 million |
| Growth rate | 11.5% (CAGR from 2023 to 2030) |
| Largest segment | Outsourcing |
| Fastest growing segment | Outsourcing |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | In-House, Outsourcing |
| Key market players worldwide | Steris PLC, Sotera Health Co Ordinary Shares, Sartorius AG, Solvias, SGS AG, Labcorp Holdings Inc, Pace Analytical Services, Charles River Laboratories International Inc, Thermo Fisher Scientific Inc, Rapid Micro Biosystems Inc Class A, Almac Group, Pacific BioLabs, Inc., Boston Analytical, Labor LS |
Other key industry trends
- In terms of revenue, Japan accounted for 4.4% of the global pharmaceutical sterility testing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China pharmaceutical sterility testing market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 251.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Sterility Testing Market Scope
Pharmaceutical Sterility Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Japan pharmaceutical sterility testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical sterility testing market will help companies and investors design strategic landscapes.
Outsourcing was the largest segment with a revenue share of 58.98% in 2023. Horizon Databook has segmented the Japan pharmaceutical sterility testing market based on in-house, outsourcing covering the revenue growth of each sub-segment from 2018 to 2030.
In December 2023, AGC declared its plan to enhance its biopharmaceutical Contract Development & Manufacturing Organization (CDMO) capabilities at the AGC Yokohama Technical Center located in Tsurumi-ku, Yokohama (referred to as the 'Yokohama Site' henceforth). The anticipated investment for this expansion is approximately USD 338.16 million (50 billion Japanese yen).
The timeline for this development includes the initiation of the development services for gene & cell therapies in 2025, followed by the commencement of the development & manufacturing services for messenger Ribonucleic Acid (mRNA) pharmaceuticals, biopharmaceuticals produced through mammalian cell cultures, and gene & cell therapies in 2026.
Reasons to subscribe to Japan pharmaceutical sterility testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Japan pharmaceutical sterility testing market databook
-
Our clientele includes a mix of pharmaceutical sterility testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan pharmaceutical sterility testing market , including forecasts for subscribers. This country databook contains high-level insights into Japan pharmaceutical sterility testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Japan pharmaceutical sterility testing market size, by type, 2018-2030 (US$M)
Japan Pharmaceutical Sterility Testing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
